Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID-19 Experience

Fasano A, Antonini A, Katzenschlager R, Krack P, Odin P, Evans AH, Foltynie T, Volkmann J, Merello M.

Mov Disord Clin Pract. 2020 May 4;7(4):361-372. doi: 10.1002/mdc3.12965. eCollection 2020 May.

Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders

Papa SM, Brundin P, Fung VSC, Kang UJ, Burn DJ, Colosimo C, Chiang HL, Alcalay RN, Trenkwalder C; MDS-Scientific Issues Committee.

Mov Disord. 2020 May;35(5):711-715. doi: 10.1002/mds.28067. Epub 2020 Apr 16.

COVID-19 infection may increase the risk of parkinsonism - Remember the Spanish flu?

Eldeeb MA, Hussain FS, Siddiqi ZA.

Cytokine Growth Factor Rev. 2020 Jun 7:S1359-6101(20)30142-8. doi: 10.1016/j.cytogfr.2020.06.009. Online ahead of print.

Movement Disorder Society-Unified Parkinson's Disease Rating Scale Use in the Covid-19 Era

Goetz CG, Stebbins GT, Luo S.

Mov Disord. 2020 Jun;35(6):911. doi: 10.1002/mds.28094. Epub 2020 May 11.

E-Rehabilitation: One solution for patients with Parkinson's disease in COVID-19 era

Srivastav AK, Samuel AJ.

Parkinsonism Relat Disord. 2020 Jun 4:S1353-8020(20)30130-9. doi: 10.1016/j.parkreldis.2020.05.021. Online ahead of print.

Movement Disorders in the World of COVID-19

Stoessl AJ, Bhatia KP, Merello M.

Mov Disord Clin Pract. 2020 Apr 16;7(4):355-356. doi: 10.1002/mdc3.12952. eCollection 2020 May.

Care, Convenience, Comfort, Confidentiality, and Contagion: The 5 C's that Will Shape the Future of Telemedicine

Dorsey ER, Okun MS, Bloem BR.

J Parkinsons Dis. 2020 Jun 8. doi: 10.3233/JPD-202109. Online ahead of print.

Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders

Papa SM, Brundin P, Fung VSC, Kang UJ, Burn DJ, Colosimo C, Chiang HL, Alcalay RN, Trenkwalder C; MDS‐Scientific Issues Committee.

Mov Disord Clin Pract. 2020 Apr 16;7(4):357-360. doi: 10.1002/mdc3.12953. eCollection 2020 May.

New onset neurologic events in people with COVID-19 infection in three regions in China

Xiong W, Mu J, Guo J, Lu L, Liu D, Luo J, Li N, Liu J, Yang D, Gao H, Zhang Y, Lin M, Shen S, Zhang H, Chen L, Wang G, Luo F, Li W, Chen S, He L, Sander JW, Zhou D.

Neurology. 2020 Jun 17:10.1212/WNL.0000000000010034. doi: 10.1212/WNL.0000000000010034. Online ahead of print.

The Challenge of Managing Parkinson's Disease Patients during the COVID-19 Pandemic

Garg D, Dhamija RK.

Ann Indian Acad Neurol. 2020 Apr;23(Suppl 1):S24-S27. doi: 10.4103/aian.AIAN_295_20. Epub 2020 Apr 20.

Disability through COVID-19 pandemic: Neurorehabilitation cannot wait

Leocani L, Diserens K, Moccia M, Caltagirone C.

Eur J Neurol. 2020 May 13:10.1111/ene.14320. doi: 10.1111/ene.14320. Online ahead of print.

Movement Disorders in the World of COVID-19

Stoessl AJ, Bhatia KP, Merello M.

Mov Disord. 2020 May;35(5):709-710. doi: 10.1002/mds.28069. Epub 2020 Apr 16.

Recommendations for Deep Brain Stimulation Device Management During a Pandemic

Miocinovic S, Ostrem JL, Okun MS, Bullinger KL, Riva-Posse P, Gross RE, Buetefisch CM.

J Parkinsons Dis. 2020 Apr 24. doi: 10.3233/JPD-202072. Online ahead of print.

Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy

Schirinzi T, Cerroni R, Di Lazzaro G, Liguori C, Scalise S, Bovenzi R, Conti M, Garasto E, Mercuri NB, Pierantozzi M, Pisani A, Stefani A.

Neurol Sci. 2020 Jun;41(6):1373-1375. doi: 10.1007/s10072-020-04442-1. Epub 2020 May 3.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System

De Felice FG, Tovar-Moll F, Moll J, Munoz DP, Ferreira ST.

Trends Neurosci. 2020 Jun;43(6):355-357. doi: 10.1016/j.tins.2020.04.004. Epub 2020 Apr 21.